Prognostic value of 18F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma

Arnoldo Piccardo, Matteo Puntoni, Egesta Lopci, Massimo Conte, Luca Foppiani, Stefania Sorrentino, Giovanni Morana, Mehrdad Naseri, Angelina Cistaro, Giampiero Villavecchia, Stefano Fanti, Alberto Garaventa

Research output: Contribution to journalArticlepeer-review


Purpose: The aim of this study was to investigate the relationship between 123I-metaiodobenzylguanidine (MIBG) scan semi-quantification and a new 18F-DOPA positron emission tomography (PET)/CT score in patients with suspected or documented neuroblastoma (NB) relapse and to assess the association between these two parameters and progression-free survival (PFS)/overall survival (OS). Methods: We analysed 24 NB patients who had undergone 123I-MIBG and 18F-DOPA PET/CT scans at the time of suspected relapse, after applying a proper scoring system for each scan. In time-to-event analyses, the score distributions were regarded as continuous and were categorized in tertiles and medians. We used Kaplan-Meier curves and Cox proportional hazard models for PFS and OS in order to estimate the independent prognostic impact of 123I-MIBG and 18F-DOPA PET/CT scans. Results: The 123I-MIBG and 18F-DOPA scores were highly and positively correlated (Spearman's rho=0.8, p123I-MIBG score>3 (3rd tertile) and an even higher risk (HR:37.2, 95 % CI 2.4-574) in those with 18F-DOPA whole-body metabolic burden (WBMB) >7.5 (median), after adjustment for all main clinical/pathological factors considered. Kaplan-Meier analyses showed a significant association with OS (log-rank p=0.01 and p=0.03 for 123I-MIBG and 18F-DOPA WBMB, respectively). Conclusion: Our results confirm the good agreement between 18F-DOPA PET/CT and 123I-MIBG scan in patients affected by NB relapse. In time-to-event analyses, 123I-MIBG scan and 18F-DOPA PET/CT scores were independently and significantly associated with disease progression.

Original languageEnglish
Pages (from-to)1046-1056
Number of pages11
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Issue number6
Publication statusPublished - 2014


  • Neuroblastoma
  • Prognostic value

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Medicine(all)


Dive into the research topics of 'Prognostic value of 18F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma'. Together they form a unique fingerprint.

Cite this